Once again we explore what new publications have been produced by HEDS in collaboration with colleagues in ScHARR. Many of these are currently in press, so you can find much of our work in its open access form via our institutional repository. Tuck in here.
Addison, M., Mcgovern, R., Angus, C., Becker, F., Brennan, A., Brown, H., Coulton, S., Crowe, L., Gilvarry, E., Hickman, M., Howel, D., Mccoll, E., Muirhead, C., Newbury-Birch, D., Waqas, M. & Kaner, E. (2018) Alcohol Screening and Brief Intervention in Police Custody Suites: Pilot Cluster Randomised Controlled Trial (AcCePT). Alcohol and Alcoholism. [Online] (agy039). https://www.ncbi.nlm.nih.gov/pubmed/29889245
|© Springer Nature|
Bates, S., Holmes, J., Gavens, L., De Matos, E. G., Li, J., Ward, B., Hooper, L., Dixon, S. & Buykx, P. (2018) Awareness of alcohol as a risk factor for cancer is associated with public support for alcohol policies. BMC Public Health. [Online] 18 (1),
Bermejo, I., Ren, S., Simpson, E., Clowes, M., Scott, D. L., Young, A. & Stevenson, M. (2018) Sarilumab for Previously-Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. Pharmacoeconomics. [Online] Available from: https://www.ncbi.nlm.nih.gov/pubmed/29882210.
Devlin, N., Brazier, J., Pickard, A. S. & Stolk, E. (2018) 3L, 5L, What the L? A NICE Conundrum. PharmacoEconomics. [Online] 36637–640.
Fuller, G. W., Goodacre, S., Keating, S., Perkins, G., Ward, M., Rosser, A., Gunson, I., Miller, J., Bradburn, M., Thokala, P., Harris, T., Carson, A., Marsh, M. & Cooper, C. (2018) The ACUTE (Ambulance CPAP: Use, Treatment effect and economics) feasibility study: a pilot randomised controlled trial of prehospital CPAP for acute respiratory failure. Pilot and Feasibility Studies. [Online] 4 (1), .
Gray, L. A., Wailoo, A. & Hernandez, M. (n.d.) Mapping the FACT-B instrument to EQ-5D-3L in Patients with Breast Cancer using Adjusted Limited Dependent Variable Mixture Models vs Response Mapping. Value in Health. http://eprints.whiterose.ac.uk/131975/
Hernandez-Villafuerte, K., Fischer, A. & Latimer, N. R. (n.d.) Challenges and Methodologies Using Progression Free Survival As A Surrogate For Overall Survival In Oncology. International Journal of Technology Assessment in Health Care. http://eprints.whiterose.ac.uk/130810/
Keetharuth, D., Taylor Buck, E., Acquadro, C., Conway, K., Connell, J., Barkham, M., Carlton, J., Ricketts, T. N., Barber, R. & Brazier, J. E. (n.d.) Integrating qualitative and quantitative data in the development of outcome measures: the case of the Recovering Quality of Life (ReQoL) measures in mental health populations. International Journal of Environmental Research and Public Health. (Special Issue ‘Mental Health and Social Care and Social Interventions’), . https://www.ncbi.nlm.nih.gov/pubmed/29949892
Kharroubi, S. & Rowen, D. L. (n.d.) Valuation of preference-based measures: Can existing preference data be used to select a smaller sample of health states? The European Journal of Health Economics. https://www.ncbi.nlm.nih.gov/pubmed/29980950
Lawton, K., Royals, K., Carson-Chahhoud, K. V, Campbell, F. & Smith, B. J. (2018) Nurse-led versus doctor-led care for bronchiectasis. Cochrane Database of Systematic Reviews. [Online] 2018 (6), . https://www.ncbi.nlm.nih.gov/pubmed/29926473
Pennington, R. M., Collins, B., Leigh, S., Martin, A. P., Owen, L., Fischer, A., Sumnall, H. & Bates, G. (2018) The cost-effectiveness of seven behavioural interventions to prevent drug misuse in vulnerable populations. International Journal of Drug Policy. [Online] 5742–50. Available from: https://www.sciencedirect.com/science/article/pii/S0955395918300987
Rowen, D. L., Labeit, A., Stevens, K., Elliot, J., Mulhern, B., Carlton, J., Basarir, H. & Brazier, J. (n.d.) Estimating a preference-based single index measuring the quality of life impact of self-management for diabetes. Medical Decision Making. https://www.ncbi.nlm.nih.gov/pubmed/29957107
Stevens, J. W. (n.d.) Using evidence from randomised controlled trials in economic models: What information is relevant and is there a minimum amount of sample data required to make decisions? PharmacoEconomics. https://www.ncbi.nlm.nih.gov/pubmed/29926358
Tappenden, P., Carroll, C., Stevens, J., Simpson, E., Thokala, P., Wong, R., Wright, J. & Auer, R. (2018) Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics. [Online] 1–12. https://www.ncbi.nlm.nih.gov/pubmed/29951793
Tes, D., Kratkiewicz, K., Aber, A., Horton, L., Zafar, M., Arafat, N., Fatima, A. & Avanaki, M. R. N. (2018) Development and Optimization of a Fluorescent Imaging System to Detect Amyloid-β Proteins: Phantom Study. Biomedical Engineering and Computational Biology. [Online] 9117959721878108–117959721878108. https://www.ncbi.nlm.nih.gov/pubmed/29977121